SEMLER SCIENTIFIC INC (SMLR) Stock Fundamental Analysis
NASDAQ:SMLR - US81684M1045 - Common Stock
31.43 USD
+1.33 (+4.42%)
31.77 USD
+0.34 (+1.08%)
Overall SMLR gets a fundamental rating of 5 out of 10. We evaluated SMLR against 185 industry peers in the Health Care Equipment & Supplies industry. SMLR has an excellent profitability rating, but there are concerns on its financial health. SMLR has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
In the past year SMLR was profitable.
SMLR had a positive operating cash flow in the past year.
Each year in the past 5 years SMLR has been profitable.
Each year in the past 5 years SMLR had a positive operating cash flow.
1.2 Ratios
With an excellent Return On Assets value of 7.09%, SMLR belongs to the best of the industry, outperforming 88.24% of the companies in the same industry.
With an excellent Return On Equity value of 9.66%, SMLR belongs to the best of the industry, outperforming 83.42% of the companies in the same industry.
With a decent Return On Invested Capital value of 0.92%, SMLR is doing good in the industry, outperforming 67.38% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for SMLR is significantly above the industry average of 8.44%.
The last Return On Invested Capital (0.92%) for SMLR is well below the 3 year average (20.14%), which needs to be investigated, but indicates that SMLR had better years and this may not be a problem.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.09% | ||
| ROE | 9.66% | ||
| ROIC | 0.92% |
ROA(3y)22.09%
ROA(5y)28.14%
ROE(3y)24.04%
ROE(5y)31.39%
ROIC(3y)20.14%
ROIC(5y)28.39%
1.3 Margins
SMLR has a Profit Margin of 86.20%. This is amongst the best in the industry. SMLR outperforms 98.93% of its industry peers.
SMLR's Profit Margin has improved in the last couple of years.
The Operating Margin of SMLR (12.16%) is better than 78.61% of its industry peers.
In the last couple of years the Operating Margin of SMLR has grown nicely.
The Gross Margin of SMLR (90.91%) is better than 98.93% of its industry peers.
SMLR's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 12.16% | ||
| PM (TTM) | 86.2% | ||
| GM | 90.91% |
OM growth 3Y0.46%
OM growth 5Y2.62%
PM growth 3Y30.79%
PM growth 5Y9.56%
GM growth 3Y1.15%
GM growth 5Y0.6%
2. Health
2.1 Basic Checks
SMLR has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
SMLR has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, SMLR has more shares outstanding
SMLR has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
SMLR has an Altman-Z score of 2.36. This is not the best score and indicates that SMLR is in the grey zone with still only limited risk for bankruptcy at the moment.
The Altman-Z score of SMLR (2.36) is better than 65.78% of its industry peers.
SMLR has a debt to FCF ratio of 7.90. This is a slightly negative value and a sign of low solvency as SMLR would need 7.90 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 7.90, SMLR is in the better half of the industry, outperforming 75.94% of the companies in the same industry.
A Debt/Equity ratio of 0.25 indicates that SMLR is not too dependend on debt financing.
SMLR's Debt to Equity ratio of 0.25 is in line compared to the rest of the industry. SMLR outperforms 51.87% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.25 | ||
| Debt/FCF | 7.9 | ||
| Altman-Z | 2.36 |
ROIC/WACC0.1
WACC8.9%
2.3 Liquidity
SMLR has a Current Ratio of 0.60. This is a bad value and indicates that SMLR is not financially healthy enough and could expect problems in meeting its short term obligations.
SMLR's Current ratio of 0.60 is on the low side compared to the rest of the industry. SMLR is outperformed by 93.05% of its industry peers.
A Quick Ratio of 0.58 indicates that SMLR may have some problems paying its short term obligations.
With a Quick ratio value of 0.58, SMLR is not doing good in the industry: 91.98% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.6 | ||
| Quick Ratio | 0.58 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 201.43% over the past year.
The Earnings Per Share has been growing by 24.17% on average over the past years. This is a very strong growth
The Revenue for SMLR has decreased by -30.40% in the past year. This is quite bad
The Revenue has been growing by 11.43% on average over the past years. This is quite good.
EPS 1Y (TTM)201.43%
EPS 3Y37.82%
EPS 5Y24.17%
EPS Q2Q%687.5%
Revenue 1Y (TTM)-30.4%
Revenue growth 3Y2.01%
Revenue growth 5Y11.43%
Sales Q2Q%-43.19%
3.2 Future
SMLR is expected to show a very negative growth in Earnings Per Share. In the coming years, the EPS will decrease by -27.06% yearly.
Based on estimates for the next years, SMLR will show a very negative growth in Revenue. The Revenue will decrease by -16.29% on average per year.
EPS Next Y-162.03%
EPS Next 2Y-42.88%
EPS Next 3Y-27.06%
EPS Next 5YN/A
Revenue Next Year-40.99%
Revenue Next 2Y-23.7%
Revenue Next 3Y-16.29%
Revenue Next 5YN/A
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
A Price/Earnings ratio of 3.74 indicates a rather cheap valuation of SMLR.
Compared to the rest of the industry, the Price/Earnings ratio of SMLR indicates a rather cheap valuation: SMLR is cheaper than 98.40% of the companies listed in the same industry.
The average S&P500 Price/Earnings ratio is at 27.24. SMLR is valued rather cheaply when compared to this.
The Forward Price/Earnings Ratio is negative for SMLR. No positive earnings are expected for the next year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 3.74 | ||
| Fwd PE | N/A |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, SMLR is valued a bit cheaper than 62.03% of the companies in the same industry.
Based on the Price/Free Cash Flow ratio, SMLR is valued a bit cheaper than the industry average as 78.07% of the companies are valued more expensively.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 38.19 | ||
| EV/EBITDA | 96.2 |
4.3 Compensation for Growth
SMLR has an outstanding profitability rating, which may justify a higher PE ratio.
A cheap valuation may be justified as SMLR's earnings are expected to decrease with -27.06% in the coming years.
PEG (NY)N/A
PEG (5Y)0.15
EPS Next 2Y-42.88%
EPS Next 3Y-27.06%
5. Dividend
5.1 Amount
No dividends for SMLR!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
31.43
+1.33 (+4.42%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners61.19%
Inst Owner Change40.39%
Ins Owners5.29%
Ins Owner Change0.32%
Market Cap465.16M
Analysts82.5
Price Target99.96 (218.04%)
Short Float %21.97%
Short Ratio2.82
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)38.03%
EPS NQ rev (1m)5%
EPS NQ rev (3m)N/A
EPS NY rev (1m)1.32%
EPS NY rev (3m)-291.76%
Revenue NQ rev (1m)0.75%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0.72%
Revenue NY rev (3m)-41.61%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 3.74 | ||
| Fwd PE | N/A | ||
| P/S | 10.82 | ||
| P/FCF | 38.19 | ||
| P/OCF | 37.33 | ||
| P/B | 1.21 | ||
| P/tB | N/A | ||
| EV/EBITDA | 96.2 |
EPS(TTM)8.41
EY26.76%
EPS(NY)-0.23
Fwd EYN/A
FCF(TTM)0.82
FCFY2.62%
OCF(TTM)0.84
OCFY2.68%
SpS2.9
BVpS25.91
TBVpS-7.67
PEG (NY)N/A
PEG (5Y)0.15
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 7.09% | ||
| ROE | 9.66% | ||
| ROCE | 1.08% | ||
| ROIC | 0.92% | ||
| ROICexc | 0.95% | ||
| ROICexgc | N/A | ||
| OM | 12.16% | ||
| PM (TTM) | 86.2% | ||
| GM | 90.91% | ||
| FCFM | 28.34% |
ROA(3y)22.09%
ROA(5y)28.14%
ROE(3y)24.04%
ROE(5y)31.39%
ROIC(3y)20.14%
ROIC(5y)28.39%
ROICexc(3y)84.34%
ROICexc(5y)123.7%
ROICexgc(3y)231.99%
ROICexgc(5y)212.29%
ROCE(3y)23.58%
ROCE(5y)33.24%
ROICexcg growth 3Y32.01%
ROICexcg growth 5Y21.37%
ROICexc growth 3Y-65.32%
ROICexc growth 5Y-45.58%
OM growth 3Y0.46%
OM growth 5Y2.62%
PM growth 3Y30.79%
PM growth 5Y9.56%
GM growth 3Y1.15%
GM growth 5Y0.6%
F-Score3
Asset Turnover0.08
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.25 | ||
| Debt/FCF | 7.9 | ||
| Debt/EBITDA | 16.92 | ||
| Cap/Depr | 60.82% | ||
| Cap/Sales | 0.65% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 218.98% | ||
| Profit Quality | 32.88% | ||
| Current Ratio | 0.6 | ||
| Quick Ratio | 0.58 | ||
| Altman-Z | 2.36 |
F-Score3
WACC8.9%
ROIC/WACC0.1
Cap/Depr(3y)171.05%
Cap/Depr(5y)155.18%
Cap/Sales(3y)1.71%
Cap/Sales(5y)1.73%
Profit Quality(3y)88.64%
Profit Quality(5y)91.36%
High Growth Momentum
Growth
EPS 1Y (TTM)201.43%
EPS 3Y37.82%
EPS 5Y24.17%
EPS Q2Q%687.5%
EPS Next Y-162.03%
EPS Next 2Y-42.88%
EPS Next 3Y-27.06%
EPS Next 5YN/A
Revenue 1Y (TTM)-30.4%
Revenue growth 3Y2.01%
Revenue growth 5Y11.43%
Sales Q2Q%-43.19%
Revenue Next Year-40.99%
Revenue Next 2Y-23.7%
Revenue Next 3Y-16.29%
Revenue Next 5YN/A
EBIT growth 1Y-75.28%
EBIT growth 3Y2.48%
EBIT growth 5Y14.34%
EBIT Next Year-327.64%
EBIT Next 3Y-39.26%
EBIT Next 5YN/A
FCF growth 1Y-37.74%
FCF growth 3Y16.95%
FCF growth 5Y17.17%
OCF growth 1Y-42.82%
OCF growth 3Y14.98%
OCF growth 5Y13.91%